DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
von Minckwitz G. et al.
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
N Engl J Med 2019;
380: 617-628
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.